More than 45 encapsulated cell therapies and encapsulation technologies are being evaluated across different phase, By Roots Analysis

Extensive research on cell encapsulation strategies has enabled the development of a variety of technologies capable of immobilizing / enclosing therapeutic entities within biocompatible matrices / carriers. Such products offer a myriad of advantages, and have demonstrated the capability to address existing challenges related to cell therapies and certain other types of interventions as well.

• A detailed assessment of the current market landscape of encapsulated cell therapies and affiliated technologies, highlighting various target disease indications, phase of development, encapsulation method, type of cells / API, and route of administration, along with information on various stakeholder companies that are developing novel encapsulation methods / techniques for use in storage and transportation of cells, as well as other applications.
• Comprehensive profiles of industry players that are currently engaged in the preclinical / clinical development of their proprietary encapsulated cell therapies, featuring an overview of the company, its financial information (if available), and a detailed description of its product(s), highlighting mechanism of action, current development status, and key preclinical / clinical trial results. Each profile also includes a list of recent developments, highlighting the key milestones achieved, partnership activity, and the likely strategies that may be adopted by these players to fuel growth in the in the foreseen future.
• An in-depth analysis of the patents that have been published related to cell encapsulation technologies, since 2013. The analysis also highlights the key trends associated with these patents, across patent type, regional applicability, CPC classification, emerging focus areas, leading industry players (in terms of number of patents filed / granted), and current intellectual property-related benchmarks and valuation.
• A comprehensive clinical trial analysis of completed, ongoing and planned studies of various encapsulated cell therapies. The analysis highlights the key trends associated with these clinical studies across various parameters, such as trial start year, trial status, phase of development, leading industry and non-industry players (in terms of number of trials conducted), study design, target therapeutic area, key indications, study focus, clinical endpoints, and enrolled patient population and regional distribution of trials.

To order this 500+ page report, which features 170+ figures and 395+ tables, please visit this https://www.rootsanalysis.com/reports/249/request-sample.html

The USD 3.7 billion (by 2030) financial opportunity within the encapsulated cell therapies and encapsulation technologies market has been analyzed across the following segments:

• Type of licensing deal payment
• Upfront payment
• Milestone payment

• Therapeutic area
• Metabolic disorder
• Neurological disorder
• Ophthalmic disorder
• Oncological disorder

• Target disease indication
• Ataxia telangiectasia
• Breast cancer
• Diabetes
• Glaucoma
• Head and neck cancer
• Macular telangectasia
• Pancreatic cancer
• Parkinson's disease
• Retinitis pigmentosa

• Type of encapsulation material used
• Alginate-based microcapsule
• Cellulose hydrogel
• Medical-grade plastic
• Red blood cell

• Key geographical region
• North America
• Europe
• Asia-Pacific and rest of the world

The Cell Encapsulation: Focus on Therapeutics and Technologies, 2019-2030 report features the following companies, which we identified to be key players in this domain: 

• ALTuCELL
• Azellon Cell Therapeutics
• Beta-Cell
• Betalin Therapeutics
• CellProtect Biotechnology
• Diatranz Otsuka
• Encellin
• EryDel
• Gloriana Therapeutics
• Living Cell Technologies
• MaxiVAX
• Neurotech Pharmaceuticals
• PharmaCyte Biotech
• Semma Therapeutics
• Sernova

Table of Contents

1.         Preface

2.         Executive Summary

3.         Introduction

4.         Current Market Landscape

5.         Encapsulated Cell Therapies and Encapsulation Technologies for Metabolic Disorders: Company Profiles

6.         Encapsulated Cell Therapies and Encapsulation Technologies for Non-Metabolic Disorders: Company Profiles

7.         Patent Analysis

8.         Clinical Trial Analysis

9.         Recent Partnerships

10.       Funding and Investment Analysis

11.       Grant Analysis

12.       Potential Strategic Partners

13.       Market Forecast

14.       Conclusion

15.       Executive Insights

16.       Appendix 1: Tabulated Data

17.       Appendix 2: List of Companies and Organizations

To purchase a copy, please visit https://rootsanalysis.com/reports/view_document/cell-encapsulation-focus-on-therapeutics-and-technologies-2019-2030/249.html

Contact:

Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091
[email protected]